A Descriptive Comparison of the Epidemiological Characteristics of Delta and Omicron Variant-Driven Outbreaks in Bhutan
Simple Summary
Abstract
1. Introduction
2. Methods
2.1. Data Collection and Analysis
2.2. Patient Involvement
2.3. Ethics Approval
3. Results
3.1. Distribution of Cases
3.2. Socio-Demographic Characteristics
3.3. Vaccination Status
3.4. Clinical Symptoms
3.5. Incubation Period
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Worldometer. COVID-19 CORONAVIRUS PANDEMIC 2022 [Updated 9th February]. Available online: https://www.worldometers.info/coronavirus/ (accessed on 9 February 2022).
- Singhal, T. The Emergence of Omicron: Challenging Times Are Here Again! Indian J. Pediatr. 2022, 89, 490–496. [Google Scholar] [CrossRef] [PubMed]
- Noureddine, F.Y.; Chakkour, M.; El Roz, A.; Reda, J.; Al Sahily, R.; Assi, A.; Joma, M.; Salami, H.; Hashem, S.J.; Harb, B.; et al. The emergence of SARS-CoV-2 variant (s) and its impact on the prevalence of COVID-19 cases in the Nabatieh Region, Lebanon. Med. Sci. 2021, 9, 40. [Google Scholar] [CrossRef] [PubMed]
- WHO. Update on Omicron: World Health Organization. 2022. Available online: https://www.who.int/news/item/28-11-2021-update-on-omicron (accessed on 9 February 2022).
- Ma, C.; Chen, X.; Mei, F.; Xiong, Q.; Liu, Q.; Dong, L.; Liu, C.; Zou, W.; Zhan, F.; Hu, B.; et al. Drastic decline in sera neutralization against SARS-CoV-2 Omicron variant in Wuhan COVID-19 convalescents. Emerg. Microbes Infect. 2022, 11, 567–572. [Google Scholar] [CrossRef] [PubMed]
- Musa, S.S.; Gyeltshen, D.; Manirambona, E.; Ayuba, D.; Lucero-Prisno, D.E. The new COVID-19 omicron variant: Africa must watch its spread! Clin. Epidemiol. Glob. Health 2022, 13, 100961. [Google Scholar] [CrossRef] [PubMed]
- Kim, M.K.; Lee, B.; Choi, Y.Y.; Um, J.; Lee, K.S.; Sung, H.K.; Kim, Y.; Park, J.S.; Lee, M.; Jang, H.C.; et al. Clinical Characteristics of 40 Patients Infected With the SARS-CoV-2 Omicron Variant in Korea. J. Korean Med. Sci. 2022, 37, e31. [Google Scholar] [CrossRef]
- Wolter, N.; Jassat, W.; Walaza, S.; Welch, R.; Moultrie, H.; Groome, M.; Amoako, D.G.; Everatt, J.; Bhiman, J.N.; Scheepers, C.; et al. Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: A data linkage study. Lancet 2022, 399, 437–446. [Google Scholar] [CrossRef]
- kuenselonline. Threat from Delta Variant at a Whole New Level: Sowai Lyonpo, Kuensel. 2021. Available online: https://kuenselonline.com/threat-from-delta-variant-at-a-whole-new-level-sowai-lyonpo/ (accessed on 9 February 2022).
- kuenselonline. Bhutan Hit with Massive COVID-19 Cases. 2022. Available online: https://kuenselonline.com/bhutan-hit-with-massive-covid-19-cases/ (accessed on 9 February 2022).
- kuenselonline. Recent Local Cases Omicron Variant. Kuensel. 2022. Available online: https://kuenselonline.com/recent-local-cases-omicron-variant/ (accessed on 9 February 2022).
- Gyem, K.; Monger, A.; Darnal, J.B.; Adhikari, L.M.; Wangchuk, S.; Dorji, T. A descriptive study of confirmed COVID-19 cases in Bhutan. J. Infect. Dis. Epidemiol. 2020, 6, 142. [Google Scholar]
- R Core Team. R: A Language and Environment for Statistical Computing; R Found Stat Comput: Vienna, Austria, 2017. [Google Scholar]
- QGIS Development Team. QGIS geographic information system. In Open Source Geospatial Foundation Project; QGIS Development Team: Bonn, Germany, 2016; Available online: https://www.qgis.org/ (accessed on 9 February 2022).
- Vogel, L. An early look at Omicron. CMAJ 2022, 194, E58. [Google Scholar] [CrossRef]
- Backer, J.A.; Eggink, D.; Andeweg, S.P.; Veldhuijzen, I.K.; van Maarseveen, N.; Vermaas, K.; Vlaemynck, B.; Schepers, R.; van den Hof, S.; Reusken, C.B.E.; et al. Shorter serial intervals in SARS-CoV-2 cases with Omicron BA.1 variant compared with Delta variant, the Netherlands, 13 to 26 December 2021. Eurosurveillance 2022, 27, 2200042. [Google Scholar] [CrossRef]
- Elliott, P.; Bodinier, B.; Eales, O.; Wang, H.; Haw, D.; Elliott, J.; Whitaker, M.; Jonnerby, J.; Tang, D.; Walters, C.E.; et al. Rapid increase in Omicron infections in England during December 2021: REACT-1 study. Science 2022, 375, eabn8347. [Google Scholar] [CrossRef]
- Rahimi, F.; Abadi, A.T.B. Omicron: A highly transmissible SARS-CoV-2 variant. Gene Rep. 2022, 27, 101549. [Google Scholar] [CrossRef] [PubMed]
- Song, J.S.; Lee, J.; Kim, M.; Jeong, H.S.; Kim, M.S.; Kim, S.G.; Yoo, H.N.; Lee, J.J.; Lee, H.Y.; Lee, S.E.; et al. Serial Intervals and Household Transmission of SARS-CoV-2 Omicron Variant, South Korea, 2021. Emerg. Infect. Dis. 2022, 28, 756. [Google Scholar] [CrossRef]
- Tian, D.; Sun, Y.; Xu, H.; Ye, Q. The emergence and epidemic characteristics of the highly mutated SARS-CoV-2 Omicron variant. J. Med. Virol. 2022, 94, 2376–2383. [Google Scholar] [CrossRef] [PubMed]
- Xu, Z.; Liu, K.; Gao, G.F. Omicron variant of SARS-CoV-2 imposes a new challenge for the global public health. Biosaf. Health 2022, 4, 147–149. [Google Scholar] [CrossRef] [PubMed]
- Chakkour, M.; Salami, A.; Olleik, D.; Kamal, I.; Noureddine, F.Y.; Roz, A.E.; Ghssein, G. Risk Markers of COVID-19, a Study from South-Lebanon. COVID 2022, 2, 867–876. [Google Scholar] [CrossRef]
- Yang, W.; Shaman, J.L. COVID-19 pandemic dynamics in South Africa and epidemiological characteristics of three variants of concern (Beta, Delta, and Omicron). Elife 2022, 11. Available online: https://elifesciences.org/articles/78933 (accessed on 9 February 2022). [CrossRef]
- Iacobucci, G. COVID-19: Runny nose, headache, and fatigue are commonest symptoms of omicron, early data show. BMJ 2021, 375, n3103. [Google Scholar] [CrossRef]
- Maisa, A.; Spaccaferri, G.; Fournier, L.; Schaeffe, J.; Deniau, J.; Rolland, P.; Coignard, B. First cases of Omicron in France are exhibiting mild symptoms, November 2021–January 2022. Infect. Dis. Now 2022, 52, 160–164. [Google Scholar] [CrossRef]
- Garrett, N.; Tapley, A.; Andriesen, J.; Seocharan, I.; Fisher, L.H.; Bunts, L.; Espy, N.; Wallis, C.L.; Randhawa, A.K.; Miner, M.D.; et al. High asymptomatic carriage with the omicron variant in South Africa. Clin. Infect. Dis. 2022, 75, e289–e292. [Google Scholar] [CrossRef]
- Kappler, M. People with Omicron Much More Likely to be Asymptomatic, Research Suggests Canada 2022 [Updated Jan 10]. Available online: https://www.healthing.ca/diseases-and-conditions/coronavirus/omicron-asymptomatic-rate/ (accessed on 17 February 2022).
- Zhou, R.; To, K.K.W.; Peng, Q.; Chan, J.M.C.; Huang, H.; Yang, D.; Lam, B.H.-S.; Chuang, V.W.-M.; Cai, J.-P.; Liu, N.; et al. Vaccine-breakthrough infection by the SARS-CoV-2 omicron variant elicits broadly cross-reactive immune responses. Clin. Transl. Med. 2022, 12, e720. [Google Scholar] [CrossRef]
- Wu, M.; Wall, E.C.; Carr, E.J.; Harvey, R.; Townsley, H.; Mears, H.V.; Adams, L.; Kjaer, S.; Kelly, G.; Warchal, S.; et al. Three-dose vaccination elicits neutralising antibodies against omicron. Lancet 2022, 399, 715–717. [Google Scholar] [CrossRef] [PubMed]
- Chau NV, V.; Ngoc, N.M.; Nguyet, L.A.; Quang, V.M.; Ny NT, H.; Khoa, D.B.; Phong, N.T.; Toan, L.M.; Hong, N.T.T.; Tuyen, N.T.K.; et al. An observational study of breakthrough SARS-CoV-2 Delta variant infections among vaccinated healthcare workers in Vietnam. EClinicalMedicine 2021, 41, 101143. [Google Scholar] [CrossRef] [PubMed]
- Christensen, P.A.; Olsen, R.J.; Long, S.W.; Subedi, S.; Davis, J.J.; Hodjat, P.; Walley, D.R.; Kinskey, J.C.; Saavedra, M.O.; Pruitt, L.; et al. Delta variants of SARS-CoV-2 cause significantly increased vaccine breakthrough COVID-19 cases in Houston, Texas. Am. J. Pathol. 2022, 192, 320–331. [Google Scholar] [CrossRef] [PubMed]
- Abdullah, F.; Myers, J.; Basu, D.; Tintinger, G.; Ueckermann, V.; Mathebula, M.; Ramlall, R.; Spoor, S.; de Villiers, T.; Van der Walt, Z.; et al. Decreased severity of disease during the first global omicron variant COVID-19 outbreak in a large hospital in tshwane, south africa. Int. J. Infect. Dis. 2021, 116, 38–42. [Google Scholar] [CrossRef] [PubMed]
- Davies, M.A.; Kassanjee, R.; Rousseau, P.; Morden, E.; Johnson, L.; Solomon, W.; Hsiao, N.Y.; Hussey, H.; Meintjes, G.; Paleker, M.; et al. Outcomes of laboratory-confirmed SARS-CoV-2 infection in the Omicron-driven fourth wave compared with previous waves in the Western Cape Province, South Africa. Trop. Med. Int. Health 2022, 27, 564–573. [Google Scholar] [CrossRef]
- Houhamdi, L.; Gautret, P.; Hoang, V.T.; Fournier, P.E.; Colson, P.; Raoult, D. Characteristics of the first 1,119 SARS-CoV-2 Omicron variant cases, in Marseille, France, November-December 2021. J. Med. Virol. 2022, 94, 2290–2295. [Google Scholar] [CrossRef]
- Veneti, L.; Bøås, H.; Kristoffersen, A.B.; Stålcrantz, J.; Bragstad, K.; Hungnes, O.; Storm, M.L.; Aasand, N.; Rø, G.; Starrfelt, J.; et al. Reduced risk of hospitalisation among reported COVID-19 cases infected with the SARS-CoV-2 Omicron BA.1 variant compared with the Delta variant, Norway, December 2021 to January 2022. Eurosurveillance 2022, 27, 2200077. [Google Scholar] [CrossRef]
- Wise, J. COVID-19: Symptomatic infection with omicron variant is milder and shorter than with delta, study reports. BMJ Br. Med. J. 2022, 377, o922. [Google Scholar] [CrossRef]
- Turner, M. Bhutan’s Decisive Response to COVID-19 Eastasiaforum. 2020. Available online: https://eastasiaforum.org/2020/11/06/bhutans-decisive-response-to-covid-19/ (accessed on 9 February 2022).
- Drexler, M. The Unlikeliest Pandemic Success Story. Atlantic 2021, 10. Available online: https://www.theatlantic.com/international/archive/2021/02/coronavirus-pandemic-bhutan/617976/ (accessed on 9 February 2022).
- Bai, Y.; Yao, L.; Wei, T.; Tian, F.; Jin, D.Y.; Chen, L.; Wang, M. Presumed Asymptomatic Carrier Transmission of COVID-19. JAMA 2020, 323, 1406–1407. [Google Scholar] [CrossRef]
- Lauer, S.A.; Grantz, K.H.; Bi, Q.; Jones, F.K.; Zheng, Q.; Meredith, H.R.; Azman, A.S.; Reich, N.G.; Lessler, J. The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application. Ann. Intern. Med. 2020, 172, 577–582. [Google Scholar] [CrossRef] [PubMed]
- WHO. Contact Tracing and Quarantine in the Context of the Omicron SARS-CoV-2 Variant; World Health Organization: Geneva, Switzerland, 2022; Available online: https://iris.who.int/bitstream/handle/10665/351949/WHO-2019-nCoV-Contact-tracing-and-quarantine-Omicron-variant-2022.1-eng.pdf?sequence=1&isAllowed=y (accessed on 9 February 2022).
- World Health Organization. Coronavirus Disease 2019 (COVID-19): Situation Report—73; World Health Organization: Geneva, Switzerland, 2019; Available online: https://iris.who.int/bitstream/handle/10665/331686/nCoVsitrep02Apr2020-eng.pdf?sequence=1&isAllowed=y (accessed on 9 February 2022).
Socio-Demographic Characteristics | Categories | Delta Outbreak (n = 1648) | Omicron Outbreak (n = 3788) | Chi-Squared Test p-Value | ||
---|---|---|---|---|---|---|
Frequency | Percent | Frequency | Percent | |||
Age group | 0–5 | 66 | 4.0% | 145 | 4.0% | <0.0001 |
6–11 | 98 | 6.0% | 223 | 6.0% | ||
12–18 | 160 | 10.0% | 284 | 7.0% | ||
19–35 | 714 | 40.0% | 1920 | 51.0% | ||
36–64 | 528 | 32.0% | 1121 | 30.0% | ||
Above 64 | 82 | 5.0% | 95 | 3.0% | ||
1648 | 97.00% | 3788 | 101.00% | |||
Gender | Female | 706 | 43.0% | 1510 | 40.0% | 0.043 |
Male | 942 | 57.0% | 2278 | 60.0% | ||
1648 | 100.00% | 3788 | ||||
Comorbidity | No | 1408 | 85.0% | 3376 | 89.0% | 0.00014 |
Yes | 240 | 15.0% | 412 | 11.0% | ||
Occupation | Business personnel | 25 | 1.5% | 130 | 3.4% | <0.0001 |
Civil servant | 57 | 3.5% | 142 | 3.7% | ||
Corporate employee | 59 | 3.6% | 124 | 3.3% | ||
Dependent/minor | 77 | 4.7% | 204 | 5.4% | ||
Dessup (volunteers) | 57 | 3.5% | 246 | 6.5% | ||
Driver | 46 | 2.8% | 217 | 5.7% | ||
Farmer | 183 | 11.1% | 123 | 3.2% | ||
Foreign expat | 54 | 3.3% | 395 | 10.4% | ||
Health worker | 6 | 0.4% | 71 | 1.9% | ||
House wife | 136 | 8.3% | 323 | 8.5% | ||
Military | 45 | 2.7% | 201 | 5.3% | ||
Private employee | 296 | 18.0% | 454 | 12.0% | ||
Religious personnel | 68 | 4.1% | 45 | 1.2% | ||
Student | 356 | 21.6% | 735 | 19.4% | ||
Unemployed | 63 | 3.8% | 125 | 3.3% | ||
Others | 120 | 7.3% | 253 | 6.7% | ||
1648 | 100.20% | 3788 | 99.90% |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Rinchen, S.; Zangpo, T.; Wangchuk, S.; Dorjee, S.; Dorji, T.; Tshering, U.; Choden, J.; Yangzom, P.; Yangzom, D.; Pempa, P.; et al. A Descriptive Comparison of the Epidemiological Characteristics of Delta and Omicron Variant-Driven Outbreaks in Bhutan. Zoonotic Dis. 2024, 4, 271-282. https://doi.org/10.3390/zoonoticdis4040023
Rinchen S, Zangpo T, Wangchuk S, Dorjee S, Dorji T, Tshering U, Choden J, Yangzom P, Yangzom D, Pempa P, et al. A Descriptive Comparison of the Epidemiological Characteristics of Delta and Omicron Variant-Driven Outbreaks in Bhutan. Zoonotic Diseases. 2024; 4(4):271-282. https://doi.org/10.3390/zoonoticdis4040023
Chicago/Turabian StyleRinchen, Sangay, Tandin Zangpo, Sonam Wangchuk, Sithar Dorjee, Tandin Dorji, Ugyen Tshering, Jamyang Choden, Pema Yangzom, Deki Yangzom, Pempa Pempa, and et al. 2024. "A Descriptive Comparison of the Epidemiological Characteristics of Delta and Omicron Variant-Driven Outbreaks in Bhutan" Zoonotic Diseases 4, no. 4: 271-282. https://doi.org/10.3390/zoonoticdis4040023
APA StyleRinchen, S., Zangpo, T., Wangchuk, S., Dorjee, S., Dorji, T., Tshering, U., Choden, J., Yangzom, P., Yangzom, D., Pempa, P., Dzed, L., Wangmo, D., & Tshokey, T. (2024). A Descriptive Comparison of the Epidemiological Characteristics of Delta and Omicron Variant-Driven Outbreaks in Bhutan. Zoonotic Diseases, 4(4), 271-282. https://doi.org/10.3390/zoonoticdis4040023